Trends in the treatment and survival of heart failure patients:
a nationwide population-based study in the Czech Republic

J 2021

Trends in the treatment and survival of heart failure patients: a nationwide population-based study in the Czech Republic

TABORSKY, Milos, Tomas SKALA, Marie LAZAROVA, Renata AIGLOVA, Jindřich ŠPINAR et. al.

Základní údaje

Originální název

Trends in the treatment and survival of heart failure patients: a nationwide population-based study in the Czech Republic

Autoři

TABORSKY, Milos (203 Česká republika), Tomas SKALA (203 Česká republika, garant), Marie LAZAROVA (203 Česká republika), Renata AIGLOVA (203 Česká republika), Jindřich ŠPINAR (203 Česká republika), Lenka ŠPINAROVÁ (203 Česká republika), Jiří VÍTOVEC (203 Česká republika), Josef KAUTZNER (203 Česká republika), Vojtech MELENOVSKY (203 Česká republika), Filip MALEK (203 Česká republika), Ladislav DUŠEK (203 Česká republika, domácí), Jiří JARKOVSKÝ (203 Česká republika, domácí), Klára BENEŠOVÁ (203 Česká republika, domácí), Marek VICHA (203 Česká republika) a Ales LINHART (203 Česká republika)

Vydání

ESC Heart Failure, San Francisco, Wiley Periodicals, 2021, 2055-5822

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30201 Cardiac and Cardiovascular systems

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 3.612

Kód RIV

RIV/00216224:14110/21:00123118

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1002/ehf2.13559

UT WoS

000686108700001

Klíčová slova anglicky

Heart failure; Incidence; Prevalence; Treatment; European Union; Czech Republic

Štítky

14119612, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 6. 12. 2021 09:26, Mgr. Tereza Miškechová

Anotace

V originále

Aims A retrospective nationwide observational analysis of diagnoses, procedures, and treatment reported to the Czech National Registry of Reimbursed Health Services between 2012 and 2018. Methods and results Prevalence of heart failure (HF) patients increased from 176 496 (1679.4 per 100 000 population) in 2012 to 285 745 (2689.0 per 100 000 population) patients in 2018 (mean age 74.4 +/- 12.8 years). In the last years, a stable incidence of HF patients was observed (544 per 100 000 population in 2016 vs. 551 per 100 000 population in 2018; P = 0.310). Mortality rate decreased from 20.55% in 2012 to 15.89% in 2018. The number of hospitalized patients remained similar (318.2 per 100 000 population in 2012 vs. 311.8 per 100 000 population in 2018; P = 0.479). The most used drugs were diuretics (173 295; 60.6%) and beta-blockers (178 823; 62.6%), followed by angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers (angiotensin-converting enzyme inhibitors 120.581; 42.2%; angiotensin II receptor blockers 47 216; 16.5%). Even though the whole number of implanted devices in HF patients increased steadily (from 25 205 in 2012 to 45 363 in 2018), the prevalence of all devices (pacemakers and defibrillators) in the HF patients remained about the same (14.3% in 2012; 15.9% in 2018). Conclusions The study included all patients with HF in the Czech Republic. These are the first nationwide data of HF epidemiology in the Eastern bloc. The incidence of HF remains stable in the last years. Due to aging of the population, the prevalence of HF significantly increased in the last 6 years. Despite a continuous increase in the prevalence of HF and a suboptimal utilization of its pharmacological therapy, mortality decreased, and the number of hospitalized patients remained the same.

Citovat

TABORSKY, Milos, Tomas SKALA, Marie LAZAROVA, Renata AIGLOVA, Jindřich ŠPINAR, Lenka ŠPINAROVÁ, Jiří VÍTOVEC, Josef KAUTZNER, Vojtech MELENOVSKY, Filip MALEK, Ladislav DUŠEK, Jiří JARKOVSKÝ, Klára BENEŠOVÁ, Marek VICHA a Ales LINHART. Trends in the treatment and survival of heart failure patients: a nationwide population-based study in the Czech Republic. ESC Heart Failure. San Francisco: Wiley Periodicals, 2021, roč. 8, č. 5, s. 3800-3808. ISSN 2055-5822. Dostupné z: https://dx.doi.org/10.1002/ehf2.13559.

@article{1807766,
   author = {Taborsky, Milos and Skala, Tomas and Lazarova, Marie and Aiglova, Renata and Špinar, Jindřich and Špinarová, Lenka and Vítovec, Jiří and Kautzner, Josef and Melenovsky, Vojtech and Malek, Filip and Dušek, Ladislav and Jarkovský, Jiří and Benešová, Klára and Vicha, Marek and Linhart, Ales},
   article_location = {San Francisco},
   article_number = {5},
   doi = {http://dx.doi.org/10.1002/ehf2.13559},
   keywords = {Heart failure; Incidence; Prevalence; Treatment; European Union; Czech Republic},
   language = {eng},
   issn = {2055-5822},
   journal = {ESC Heart Failure},
   title = {Trends in the treatment and survival of heart failure patients: a nationwide population-based study in the Czech Republic},
   url = {https://onlinelibrary.wiley.com/doi/10.1002/ehf2.13559},
   volume = {8},
   year = {2021}
}

TY  - JOUR
ID  - 1807766
AU  - Taborsky, Milos - Skala, Tomas - Lazarova, Marie - Aiglova, Renata - Špinar, Jindřich - Špinarová, Lenka - Vítovec, Jiří - Kautzner, Josef - Melenovsky, Vojtech - Malek, Filip - Dušek, Ladislav - Jarkovský, Jiří - Benešová, Klára - Vicha, Marek - Linhart, Ales
PY  - 2021
TI  - Trends in the treatment and survival of heart failure patients: a nationwide population-based study in the Czech Republic
JF  - ESC Heart Failure
VL  - 8
IS  - 5
SP  - 3800-3808
EP  - 3800-3808
PB  - Wiley Periodicals
SN  - 20555822
KW  - Heart failure
KW  - Incidence
KW  - Prevalence
KW  - Treatment
KW  - European Union
KW  - Czech Republic
UR  - https://onlinelibrary.wiley.com/doi/10.1002/ehf2.13559
N2  - Aims A retrospective nationwide observational analysis of diagnoses, procedures, and treatment reported to the Czech National Registry of Reimbursed Health Services between 2012 and 2018. Methods and results Prevalence of heart failure (HF) patients increased from 176 496 (1679.4 per 100 000 population) in 2012 to 285 745 (2689.0 per 100 000 population) patients in 2018 (mean age 74.4 +/- 12.8 years). In the last years, a stable incidence of HF patients was observed (544 per 100 000 population in 2016 vs. 551 per 100 000 population in 2018; P = 0.310). Mortality rate decreased from 20.55% in 2012 to 15.89% in 2018. The number of hospitalized patients remained similar (318.2 per 100 000 population in 2012 vs. 311.8 per 100 000 population in 2018; P = 0.479). The most used drugs were diuretics (173 295; 60.6%) and beta-blockers (178 823; 62.6%), followed by angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers (angiotensin-converting enzyme inhibitors 120.581; 42.2%; angiotensin II receptor blockers 47 216; 16.5%). Even though the whole number of implanted devices in HF patients increased steadily (from 25 205 in 2012 to 45 363 in 2018), the prevalence of all devices (pacemakers and defibrillators) in the HF patients remained about the same (14.3% in 2012; 15.9% in 2018). Conclusions The study included all patients with HF in the Czech Republic. These are the first nationwide data of HF epidemiology in the Eastern bloc. The incidence of HF remains stable in the last years. Due to aging of the population, the prevalence of HF significantly increased in the last 6 years. Despite a continuous increase in the prevalence of HF and a suboptimal utilization of its pharmacological therapy, mortality decreased, and the number of hospitalized patients remained the same.
ER  -

TABORSKY, Milos, Tomas SKALA, Marie LAZAROVA, Renata AIGLOVA, Jindřich ŠPINAR, Lenka ŠPINAROVÁ, Jiří VÍTOVEC, Josef KAUTZNER, Vojtech MELENOVSKY, Filip MALEK, Ladislav DUŠEK, Jiří JARKOVSKÝ, Klára BENEŠOVÁ, Marek VICHA a Ales LINHART. Trends in the treatment and survival of heart failure patients: a nationwide population-based study in the Czech Republic. \textit{ESC Heart Failure}. San Francisco: Wiley Periodicals, 2021, roč.~8, č.~5, s.~3800-3808. ISSN~2055-5822. Dostupné z: https://dx.doi.org/10.1002/ehf2.13559.

Podrobný výpis o publikaci